Review

Septic shock, vasoactive therapy, and ventriculo-arterial decoupling

Septic shock is one of the most clinically relevant settings in which ventriculo-arterial coupling may become markedly impaired [16]. Human studies have demonstrated ventriculo-arterial uncoupling during septic shock, reflecting an imbalance between ventricular contractile performance and arterial load [17]. This condition cannot be understood solely as a disorder of vascular tone because myocardial depression, vasoplegia, tachycardia, altered vascular impedance, and vasoactive therapy may interact simultaneously. Mean arterial pressure may therefore appear adequate despite inefficient ventricular energy transfer, reduced stroke volume reserve, or persistent tissue hypoperfusion.

Heart-rate modulation may influence this interaction in selected patients. In septic shock, heart-rate reduction with esmolol has been associated with improved arterial elastance [18]. This finding suggests that persistent tachycardia may contribute to mechanical inefficiency in some patients rather than functioning exclusively as a compensatory response. The available evidence is observational, and beta-blockade should not be generalized to unstable patients without careful assessment of ventricular function, perfusion, and compensatory reserve.

Vasoactive and emerging hemodynamic therapies may also modify coupling through their effects on vascular tone, myocardial contractility, arterial compliance, and total arterial load [19]. Their effects should therefore be interpreted according to changes in forward flow and cardiovascular efficiency rather than arterial pressure alone. Noninvasive approaches, including aortic wave-intensity analysis combined with central blood pressure and phase-contrast cardiovascular magnetic resonance, may provide additional characterization of ventriculo-arterial interaction without invasive pressure-volume measurements [20]. These techniques remain technically demanding and require broader validation before routine use in rapidly changing septic shock states.

Norepinephrine response and early resuscitation

Ventriculo-arterial coupling may help explain why vasopressor-induced increases in arterial pressure do not always improve forward flow [21]. In septic shock, left ventriculo-arterial coupling has been evaluated as a predictor of stroke-volume response to norepinephrine [22]. When ventricular contractile reserve is limited, an increase in aortic pressure may occur without producing a corresponding improvement in stroke volume. A pressure response should therefore not be interpreted automatically as evidence of improved cardiovascular efficiency.

The related role of dynamic arterial elastance in distinguishing volume responsiveness from arterial pressure responsiveness is discussed separately in the dedicated section below [23]. Early studies have also examined ventriculo-arterial coupling as a potential resuscitation target in septic shock [24]. These findings support physiological plausibility but do not yet establish coupling-guided management as a standard therapeutic strategy. Larger trials are required to determine whether this approach improves organ perfusion, reduces vasopressor exposure, or produces better patient-centered outcomes. The stepwise clinical integration of ventriculo-arterial coupling in acute resuscitation is summarized in Figure 2.

Figure 2: Clinical application pathway for ventriculo-arterial coupling assessment.

Noninvasive assessment and physiological variability

Ventriculo-arterial coupling is difficult to assess during rapidly changing hemodynamic states because preload, afterload, heart rate, vascular tone, and contractility may change within minutes. A single measurement may therefore represent only a transient cardiovascular condition rather than a stable physiological relationship [25]. This limitation is particularly relevant during shock, perioperative instability, and vasoactive-drug titration, when an increase in arterial pressure or stroke volume may occur without a corresponding improvement in mechanical efficiency [26]. Coupling should therefore be interpreted serially, before and after a defined intervention, rather than from an isolated measurement.

The principal challenge in translating ventriculo-arterial coupling from an experimental construct to clinical practice is obtaining reliable noninvasive measurements [27]. Invasive pressure-volume analysis remains the reference method but is not suitable for repeated bedside assessment [28]. Single-beat methods can estimate left ventricular end-systolic elastance without conductance catheterization and may improve the feasibility of coupling assessment in cardiology, perioperative medicine, and critical care [29]. Serial assessment is particularly important during acute circulatory failure, when therapeutic interventions and rapidly changing loading conditions may alter coupling over short periods. These methods remain dependent on assumptions regarding ventricular pressure, volume, timing, and loading conditions, all of which may be unstable during acute circulatory failure.

Universal thresholds are further limited by physiological variability. Normal human coupling relationships demonstrate that ventriculo-arterial interaction is context dependent rather than fixed [30]. Age-related arterial stiffening, altered ventricular compliance, and reduced contractile reserve may shift coupling even in the absence of overt systolic dysfunction [31]. Coupling also changes with physiological demand because exercise requires coordinated adaptation of heart rate, ventricular contractility, vascular tone, and pulsatile arterial load [32]. Noninvasive coupling assessment is therefore best used as a serial and context-dependent interpretive tool rather than as an isolated diagnostic marker. Table 1 summarizes the principal clinical applications and limitations of noninvasive assessment.

Assessment domain | Clinical relevance | Main interpretive limitation | References
Single-beat estimation of end-systolic elastance | Enables approximation of ventricular contractile properties without invasive pressure-volume catheterization | Depends on assumptions regarding ventricular pressure, volume, timing, and loading conditions | [29]
Normal human coupling relations | Demonstrates that coupling reflects interaction between ventricular performance and arterial properties | Limits the use of a single universal normal range | [30]
Age-related coupling changes | Explains how arterial stiffening and altered ventricular compliance affect cardiovascular reserve | Age-related shifts may mimic or mask disease-related coupling abnormalities | [31]
Coupling during physiological demand | Shows that ventricular-arterial interaction changes during exercise and stress | Resting estimates may underestimate abnormalities that appear only under increased demand. | [32]

Ventriculo-arterial coupling in heart failure

Ventriculo-arterial coupling provides a useful framework for understanding heart failure because cardiovascular performance depends on both ventricular contractile reserve and the arterial load against which the ventricle ejects. Impaired myocardial function, increased arterial stiffness, reduced vascular compliance, and abnormal wave reflections may act together to decrease mechanical and energetic efficiency [33]. Ejection fraction alone may not adequately represent the ability of the ventricle to adapt to arterial load. Patients with similar ejection fractions may therefore have different hemodynamic profiles, exercise capacities, cardiovascular reserve, and risks of decompensation.

Abnormal coupling in chronic heart failure has been associated with ventricular remodeling and prognosis, indicating that ventricular-arterial interaction reflects more than isolated systolic function [34]. These associations support the value of coupling for disease characterization and risk assessment. Evidence that coupling-directed interventions improve survival, hospitalization, or functional outcomes remains limited.

This distinction is particularly relevant in heart failure with preserved ejection fraction. Combined ventricular systolic stiffening and arterial stiffening may impair systolic and diastolic reserve without reducing the ejection fraction [35]. This interaction provides a physiological explanation for blood pressure sensitivity, exertional intolerance, and limited hemodynamic adaptability. Chronic heart failure should therefore be viewed as a continuum of ventricular-vascular abnormalities rather than as a single pattern of coupling failure [36]. The principal current value of ventriculo-arterial coupling lies in clarifying disease mechanisms and phenotypes. Routine clinical implementation requires standardized measurement methods, phenotype-specific reference values, and evidence that coupling-guided management improves clinically meaningful outcomes.

Windkessel physiology, pressure-volume analysis, and clinical translation

The Windkessel model provides a simplified representation of the arterial contribution to ventriculo-arterial coupling. The arterial system is not a rigid conduit. Large elastic arteries temporarily store part of the energy generated during systole and release it during diastole, thereby reducing pulsatile flow and maintaining forward perfusion between ventricular ejections [37]. Effective arterial elastance reflects more than systemic vascular resistance and is influenced by arterial compliance, characteristic impedance, heart rate, stroke volume, and ventricular ejection timing. Simplified Windkessel models may not fully represent regional vascular heterogeneity, wave reflections, or disease-related structural changes in the arterial system.

Invasive pressure-volume analysis remains the most direct method for evaluating ventricular mechanics and ventriculo-arterial interaction. It permits detailed assessment of ventricular elastance, loading dependence, pressure-volume relationships, and energetic efficiency [38]. Its clinical feasibility is limited by the need for invasive catheterization, making it unsuitable for routine or repeated monitoring in most critically ill patients.

Clinical translation, therefore, depends on pragmatic monitoring approaches in perioperative and intensive care settings. Ventriculo-arterial coupling may assist in interpreting hemodynamic instability during fluid shifts, vasopressor or inotrope administration, anesthesia, and mechanical ventilation [39]. Its principal value lies in determining whether an intervention improves forward flow and cardiovascular efficiency or merely raises arterial pressure. Noninvasive assessment of ventricular elastance is feasible in the intensive care unit, but agreement among available methods remains inconsistent [40]. Standardized acquisition protocols, serial interpretation, and outcome-based validation are required before coupling can be used as an independent therapeutic target in critical care.

Dynamic arterial elastance, fluid responsiveness, and sepsis management

Dynamic arterial elastance provides a functional estimate of whether an increase in stroke volume is likely to produce a clinically meaningful increase in arterial pressure. It is commonly calculated as the ratio of pulse pressure variation to stroke volume variation and has been proposed as a predictor of arterial pressure response to volume loading in preload-dependent patients [41]. Fluid responsiveness and pressure responsiveness are not equivalent. An increase in stroke volume after fluid administration may fail to restore arterial pressure when vascular tone, arterial loading, or ventriculo-arterial energy transfer remains impaired.

Dynamic arterial elastance has also been evaluated in spontaneously breathing patients, in whom prediction is more difficult because respiratory changes in preload are less controlled than during mechanical ventilation [42]. It may help relate volume responsiveness to vascular pressure responsiveness and distinguish patients who may benefit from fluid administration from those who may require adjustment of vasopressor therapy. Reliability may be reduced by arrhythmias, spontaneous respiratory effort, variations in tidal volume, right ventricular dysfunction, vasoplegia, and differences among monitoring platforms. Dynamic arterial elastance should therefore be interpreted as a context-dependent hemodynamic signal rather than as a universal decision rule.

In septic shock, hemodynamic management requires integration of perfusion targets, fluid therapy, vasopressor use, cardiac function, and repeated reassessment [43]. Dynamic arterial elastance and ventriculo-arterial coupling may help determine whether hypotension predominantly reflects preload insufficiency, vascular hyporesponsiveness, impaired myocardial contractility, or inefficient ventriculo-arterial interaction. These indices remain adjuncts to comprehensive bedside assessment and should not be used as stand-alone therapeutic endpoints. Their broader clinical adoption requires standardized measurement conditions and prospective evidence demonstrating improvement in organ perfusion, treatment exposure, or patient-centered outcomes. Table 2 summarizes the clinical applications and principal limitations of dynamic arterial elastance in fluid administration, arterial pressure assessment, sepsis management, and pediatric ventriculo-arterial assessment.

Concept | Clinical relevance | Main interpretive limitation | References
Dynamic arterial elastance | Estimates whether an increase in stroke volume is likely to produce a meaningful rise in arterial pressure after volume loading. | Fluid responsiveness does not necessarily indicate pressure responsiveness when vascular tone or arterial load is impaired. | [41]
Assessment of spontaneously breathing patients | Extends pressure-response assessment beyond controlled mechanical ventilation. | Respiratory variability, spontaneous effort, arrhythmias, and tidal volume changes may reduce reliability. | [42]
Sepsis and septic shock resuscitation | Places dynamic arterial elastance within broader resuscitation involving fluids, vasopressors, perfusion targets, and repeated reassessment. | Should not replace integrated assessment of perfusion, cardiac function, and therapeutic response. | [43]

Pediatric validation and future clinical integration

Pediatric application of ventriculo-arterial coupling requires dedicated evaluation because cardiovascular mechanics differ substantially between children and adults. Developmental variations in heart rate, ventricular size, myocardial compliance, vascular resistance, arterial elasticity, and cardiovascular reserve influence ventriculo-arterial interaction [1,2]. Population-specific interpretation is further supported by age- and sex-related variability in noninvasive coupling estimates [3]. In pediatric critical care, interpretation is particularly complex because ventricular performance and arterial load may change rapidly during shock, postoperative instability, mechanical ventilation, vasoactive-drug administration, and fluctuating loading conditions [11,25].

Noninvasive assessment is especially important in children because invasive pressure-volume analysis, despite remaining the physiological reference standard, is impractical for routine or repeated bedside use [27,38]. Echocardiographic techniques have increased the feasibility of estimating ventricular mechanics and arterial loading, although these methods depend on assumptions regarding ventricular pressure, volume, timing, and loading conditions [29,40]. In pediatric pulmonary arterial hypertension, impaired ventricular-vascular coupling has been associated with adverse clinical outcomes, supporting its potential prognostic relevance in selected populations [44]. This evidence primarily concerns right ventricular-pulmonary arterial coupling and should not be interpreted as directly equivalent to systemic left ventriculo-arterial coupling. Simultaneous echocardiographic and conductance-catheter assessment has also demonstrated the feasibility of evaluating left ventricular mechanics in children, although available validation studies remain small and encompass limited disease spectra and severity ranges [45]. Interpretation may be further affected by small ventricular volumes, high heart rates, limited acoustic windows, sedation, mechanical ventilation, and vasoactive therapy.

Future clinical implementation requires age-specific reference ranges, disease-specific thresholds, standardized echocardiographic acquisition protocols, and validation in pediatric critical care, congenital heart disease, pulmonary hypertension, and perioperative populations. Coupling indices should be interpreted alongside ventricular function, preload responsiveness, arterial pressure response, vascular tone, and the patient's therapeutic trajectory [41,42]. Pediatric ventriculo-arterial coupling remains a physiologically informative but clinically incompletely validated framework. It may currently support mechanistic interpretation and risk stratification in selected settings, but coupling-guided interventions cannot be recommended for routine pediatric practice until prospective studies demonstrate reproducibility, therapeutic utility, and improvement in clinically meaningful outcomes.

Limitations and future directions

This narrative review has a few limitations. It did not use formal systematic screening, standardized risk-of-bias assessment, or quantitative synthesis, which limits reproducibility and may introduce selection bias. The evidence base is heterogeneous and includes animal experiments, invasive pressure-volume studies, noninvasive validation studies, consensus statements, and early clinical investigations. These sources provide complementary physiological insights but differ substantially in design, population, measurement technique, and clinical applicability.

Ventriculo-arterial coupling is also assessed using multiple approaches, including invasive pressure-volume analysis, echocardiographic estimation, effective arterial elastance, dynamic arterial elastance, and cardiovascular magnetic resonance. This methodological diversity limits direct comparison across studies and complicates the definition of clinically meaningful thresholds. Findings derived from stable experimental conditions may not be fully generalizable to critically ill patients, in whom preload, afterload, vascular tone, heart rate, and contractility can change rapidly.

Future research should prioritize standardized acquisition and calculation protocols and establish clinically relevant thresholds across age groups, sexes, disease phenotypes, and care settings. Larger prospective studies are required to compare noninvasive methods with invasive pressure-volume analysis in septic shock, heart failure, perioperative instability, and pediatric critical care. Outcome-based trials should determine whether coupling-guided management improves organ perfusion, reduces vasopressor exposure, enhances cardiovascular efficiency, shortens intensive care unit stay, or reduces mortality.

Bedside echocardiography, continuous hemodynamic monitoring, and computational models may support real-time interpretation, but these approaches require further validation before routine implementation. The central challenge is to translate ventriculo-arterial coupling from a physiologically coherent concept into a reproducible, clinically practical, and outcome-relevant decision-support framework.